Orthogonal method development and validation of reverse phase ultra-performance liquid chromatographic-mass spectrometry (using PDA and QDa mass detector) for quantification of temsirolimus in temsiro

Journal Title: Journal of Pharmaceutical and Biological Sciences - Year 2017, Vol 5, Issue 6

Abstract

In this study a sensitive, specific and stability-indicating Ultra performance liquid chromatographic (Waters ACQUITY UPLC H-class PDA with integrated QDa mass detector) assay method is developed and validated for the quantification of Temsirolimus in Temsirolimus injection. UPLC separation is achieved with a YMC Pack Pro C18 RS (100 mm x 4.6mm id x 3µm) as stationary phase and 0.05% Trifluoro acetic acid (pH adjusted to 3.0 with ammonia solution):Methanol : Acetonitrile (25:60:15, v/v) as eluent, with a flow rate 0.7 ml/min. UV detection was performed at 280 nm. The retention time of Temsirolimus peak is about 20 minutes. The method has been fully validated and is linear. Results of analysis are validated statistically and by recovery studies. The standard and sample solutions are stable up to 24 hours at 5ËšC. Temsirolimus was found to degrade in all stress conditions. Purity of Temsirolimus was found to be less than purity threshold and no additional mass interference was found at Temsirolimus peak in all controlled and stressed samples. No interference was found from corresponding stressed blank with Temsirolimus peak. This method offers advantages over using photodiode-array UV detection (LC-PDA) for the determination of UPLC peak purity, namely components with similar UV spectra can be distinguished, the molecular mass of the impurity can be determined and structural data can be obtained by using QDa mass detector. The result of studies showed that the proposed RP-UPLC method is found to be precise, linear, accurate, rugged, selective, specific, and robust and stability indicating. Hence this method can be used for the routine analysis in bulk drug and in its pharmaceutical dosage forms.

Authors and Affiliations

C. V. Nageswara Rao, Gorla Sanjeeva Reddy

Keywords

Related Articles

Chronic agmatine treatment modulates behavioral deficits induced by chronic unpredictable stress in wistar rats

Aim Stressful life events modifies brain neuronal structure that impairs normal brain functions and leads to behavioral deficiencies Agmatine is a wellrecognized neurotransmitter and has been reported to be released as a...

Perioperative antimicrobial prophylaxis in surgery and adherence to guidelines

Introduction Surgical Antimicrobial Prophylaxis SAP lowers postoperative surgical site infection SSI if used with American Society of HealthSystem Pharmacists ASHP guidelinesObjective The present study was carried out wi...

Study on the effects of fast food on the glucose and lipid profile aims to provide a platform to advocate a healthier lifestyle and better eating habits

Foods that contain saturated fat can cause an increase in cholesterol. Saturated fat is mostly found in animal-based food products such: cheese, milk, butter and steak. Some plant-based foods, such as palm oil and coconu...

Study of the fluvastatin effect on phenytoin disposition in healthy male rabbits

Introduction: Drug-drug interaction is a serious problem facing patients with chronic diseases like epilepsy; it is also an important reason for drugs refusal and withdrawal from markets. That makes the study and evaluat...

Evaluation of management and human resource challenges in the establishment of telemedicine in bandar abbas social security hospital, 2017

Objective The emergence of internet and its development has made a lot of changes in every science and industry medical science is not an exception and the internet in addition to the effects it has made on its own devel...

Download PDF file
  • EP ID EP322793
  • DOI -
  • Views 127
  • Downloads 0

How To Cite

C. V. Nageswara Rao, Gorla Sanjeeva Reddy (2017). Orthogonal method development and validation of reverse phase ultra-performance liquid chromatographic-mass spectrometry (using PDA and QDa mass detector) for quantification of temsirolimus in temsiro. Journal of Pharmaceutical and Biological Sciences, 5(6), 278-289. https://www.europub.co.uk/articles/-A-322793